News
Global health leaders unite to unlock the value of diagnostics in the fight against antimicrobial resistance.
Swipe to discover more
-
bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies
bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioMérieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide. -
Is Flu/COVID/RSV Testing Enough? A Comparison of Multiplex Respiratory Testing
This articles features a comparison of the performance of BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel, Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV, and Cobas® SARS-CoV-2 & Influenza A/B assay for detection of respiratory viruses.
-
Food Safety Trends Building Momentum into 2026
As 2026 begins, bioMérieux proudly continues our tradition of looking into the next twelve months and analyzing how key food safety trends will influence the food supply chain and our partners’ operations. The three identified trends for 2026 will continue to develop and inform food safety and quality standards — standards that we at bioMérieux are proud to help pioneer and contribute to.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19